Order results by:
| Issue | Title | |
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Efficacy and tolerance of intravenous lacosamide in urgent neurological situations | Abstract similar documents |
| P. N. Vlasov, E. G. Kamelkova, F. R. Drozzhina | ||
| "... The authors analyze the efficacy of intravenous lacosamide (LCSM) in combined therapy for partial ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Intravenous Antiepileptic Drugs in Russia | Abstract similar documents |
| P. N. Vlasov | ||
| "... Launching four intravenous antiepileptic drugs: valproate (Depakene and Convulex), lacosamide ..." | ||
| No 1S (2016): | Status epilepticus: Analysis of refractory cases | Abstract similar documents |
| B. P. Gladov, O. A. Podgornaya, P. N. Vlasov | ||
| "... electroencephalography monitoring. The investigators evaluated the efficiency of treatment regimens with intravenous ..." | ||
| Vol 12, No 3 (2020) | The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index | Abstract PDF (Eng) similar documents |
| V. A. Karlov, P. N. Vlasov, A. B. Kozhokaru, A. S. Samoilov, A. S. Orlova | ||
| "... Lacosamide (LCM) is one of the most promising antiepileptic drugs (AEDs) for focal epilepsy (FE ..." | ||
| Vol 2, No 1 (2010) | EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE | Abstract similar documents |
| T. V. Demin, M. V. Saikhunov, D. R. Khasanova | ||
| "... The authors' experience leads to the conclusion that intravenous thrombolytic therapy (TLT ..." | ||
| Vol 3, No 1 (2011) | Experience in using intravenous thrombolysis in ischemic stroke in Tatarstan | Abstract similar documents |
| D. R. Khasanova, T. V. Demin | ||
| "... The paper describes experience with intravenous thrombolysis used in a few vascular centers ..." | ||
| Vol 5, No 3 (2013) | Thrombolytic therapy for ischemic stroke | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... Systemic intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Clinical and electroencephalographic polymorphism of malignant migrating partial seizures in infancy | Abstract similar documents |
| A. A. Kholin | ||
| "... and reduce seizure frequency in 3 cases of benzo-diazepine-resistant SE in MMPSI. Intravenous convulex ..." | ||
| Vol 9, No 3 (2017) | Capabilities of perfusion ASPECTS in predicting the efficiency of intravenous thrombolytic therapy | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, V. E. Drobakha, N. A. Kaileva, L. I. Syromyatnikova, Yu. A. Golosova, V. V. Shestakov | ||
| Vol 10, No 3 (2018) | Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window | Abstract similar documents |
| K. S. Knni, T. V. Dyomin, L. B. Adeeva | ||
| "... Objective: to evaluate the effect of intravenous mexidol on the efficiency of intravenous ..." | ||
| Vol 17, No 3 (2025) | Efficacy and safety of intravenous thrombolytic therapy in patients with ischemic stroke and mild neurological deficit | Abstract similar documents |
| M. R. Suleymanova, T. V. Danilova, D. R. Khasanova | ||
| "... Intravenous thrombolytic therapy (IV TLT) is the main method of reperfusion therapy for ischemic ..." | ||
| Vol 4, No 4 (2012) | The mechanisms of reperfusion during in stroke patients treated with intravenous thrombolysis | Abstract similar documents |
| Maksim Alekseyevich Domashenko, M Yu Maksimova, M A Loskutnikov, A A Nikonov, V V Bryukhov, A S Suslin, M V Dreval, R N Konovalov | ||
| "... Systemic (intravenous) thrombolysis with recombinant tissue plasminogen activator (rt-PA ..." | ||
| Vol 13, No 4 (2021) | Pharmacodynamic sodium channel blockers-induced seizure aggravation in patients with newly diagnosed focal epilepsy | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, A. M. Azhigova, A. B. Kozhokaru, A. S. Orlova | ||
| "... of seizures occurred in patients on oxcarbazepine, carbamazepine, and lacosamide therapy. Results ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Long-term levetiracetam monotherapy for partial epilepsy in adults | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, E. G. Komelkova, Z. S. Shakhabasova | ||
| "... больных парциальной эпилепсией в возрасте 16—73 лет. У 71 пациента ЛТЦ был назначен в качестве исходной ..." | ||
| Vol 5, No 3 (2013) | Miller–Fisher syndrome | Abstract similar documents |
| Anna Vladimirovna Kraeva, A B Galunova, L I Volkova | ||
| "... regressed due to a plasmapheresis session and intravenous immunoglobulin injection. ..." | ||
| Vol 2, No 1 (2010) | NEUROPSYCHOLOGICAL SYNDROMES OF HIGHER PSYCHIC FUNCTIONS IN CHILDREN AND ADOLESCENTS WITH FOCAL FORMS OF EPILEPSY | Abstract similar documents |
| Yu. V. Mikadze, T. Yu. Gogberashvili | ||
| "... высших психических функций (ВПФ) при разных по локализации эпилептического очага парциальных (фокальных ..." | ||
| Vol 2, No 3 (2010) | Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy | Abstract similar documents |
| E. D. Belousova | ||
| "... качестве первой монотерапии впервые выявленной или недавно диагностированной парциальной эпилепсии ..." | ||
| No 1S (2016): | Clinical and electroencephalographic characteristics of some forms of epileptic encephalopathies in infants: The data of the authors' follow-up observations | Abstract similar documents |
| I. D. Lemeshko, K. V. Voronkova | ||
| "... форм детской эпилепсии, таких как злокачественные мигрирующие парциальные приступы младенчества (ЗМППМ ..." | ||
| No 1S (2016): | Russian experience with perampanel in routine clinical practice | Abstract similar documents |
| V. A. Karlov, O. V. Belyaev, P. N. Vlasov, I. A. Zhidkova, I. V. Volkov, D. V. Dmitrenko, A. Yu. Karas, T. V. Kazennykh, O. I. Miguskina, A. V. Moskvicheva, E. N. Paramonova, I. V. Ponomareva, A. V. Chervyakov | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Analysis of the clinical experience with perampanel in the Moscow Region: Efficacy, tolerability, individual choice priorities | Abstract similar documents |
| I. G. Rudakova, Yu. A. Belova | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | A Clinical Analysis of Two Cases of Refractory Status Epilepticus of Generalized Convulsive Seizures | Abstract similar documents |
| V. A. Karlov, I. A. Zhidkova, P. N. Vlasov, B. P. Gladov, O. A. Podgornaya, S. V. Ukhanova | ||
| "... and the possibilities for using intravenous forms of antiepileptic drugs in combination with general anesthetic drugs ..." | ||
| Vol 17, No 3 (2025) | Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice | Abstract similar documents |
| A. N. Boyko, T. O. Simaniv, T. A. Prokopyeva, S. V. Petrov, M. V. Melnikov | ||
| "... necessitate switching from the better-known intravenous drug ocrelizumab to the subcutaneous agent ofatumumab ..." | ||
| Vol 4, No 4 (2012) | Subtypes of ischemic cerebral circulation disorders at young age: diagnosis and treatment | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... for IS. It is pointed out that the leading therapy option in these patients is thrombolysis; intravenous recombinant ..." | ||
| Vol 1, No 3-4 (2009) | CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS | Abstract similar documents |
| V. A. Parfenov | ||
| "... evidence for the efficacy of intravenous or oral citicolin used within the first 24 hours of ischemic ..." | ||
| Vol 7, No 3 (2015) | Specific features of reperfusion therapy for vertebrobasilar ischemic stroke | Abstract similar documents |
| K. V. Anisimov, A. P. Tolmachev, Nikolai Anatolyevich Shamalov | ||
| "... in a shorter period of time and to use the advantages of both reperfusion techniques. Intravenous thrombolysis ..." | ||
| Vol 2, No 4 (2010) | Experience in using ceretone (choline alfoscerate) in brain concussion | Abstract similar documents |
| N. G. Voropay, O. B. Doronina, B. M. Doronin | ||
| "... sleepiness, anxiety, and bad mood. Thirty-nine patients received intravenous ceretone® in a dose of 1000 mg ..." | ||
| Vol 3, No 1 (2011) | Current aspects of the epidemiology and treatment of chronic brain ischemiain the presence of essential hypertension (results of the CALIPSO program) | Abstract similar documents |
| E. I. Chukanova | ||
| "... . The patients received dropwise intravenous Cavinton as infusions within the first week (25 mg on days 1 to 4 ..." | ||
| Vol 7, No 4 (2015) | Endovascular treatments for ischemic stroke: Present status and prospects | Abstract similar documents |
| A. V. Savello, D. V. Svistov, V. A. Sorokoumov | ||
| "... . Interventional treatments for IS should not be set off against intravenous thrombolytic therapy (ITT ..." | ||
| Vol 12, No 2 (2020) | Patent foramen ovale-related stroke: diagnostic approaches and the possibility of endovascular prophylaxis (clinical cases and literature review) | Abstract similar documents |
| A. A. Kulesh, D. V. Ognerubov, S. A. Mekhryakov, E. V. Merkulov, L. I. Syromyatnikova, A. S. Tereshchenko, A. N. Samko, V. V. Shestakov, Yu. V. Karakulova | ||
| "... underwent intravenous thrombolysis; control brain MRI revealed a right parietal lobe stroke. Standard ..." | ||
| No 1S (2016): | Partial epilepsies: Choice of antiepileptic drugs in adults in the outpatient setting | Abstract similar documents |
| P. N. Vlasov | ||
| "... chrono or Depakine chronosphere and its intravenous formulation, favorable pharmacokinetic ..." | ||
| Vol 6, No 1 (2014) | The use of neurocytoprotectors to improve rehabilitation of patients after cerebrovascular accident | Abstract similar documents |
| V.V. Kovalchuk | ||
| "... received intravenous infusion of Thiocetam at a dose of 30 ml for 14 days, then 1 tablet TID for 1 month ..." | ||
| Vol 15, No 3 (2023) | Cefepime-induced encephalopathy | Abstract similar documents |
| T. N. Pushkar, P. N. Vlasov, A. I. Belyakova-Bodina, A. G. Broutian | ||
| "... with intravenous administration of an antiepileptic drug (levetiracetam) was negative. A day after the withdrawal ..." | ||
| Vol 14, No 5 (2022) | Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova | ||
| "... , which assessed the efficacy and safety of sequential therapy with Mexidol®, a solution for intravenous ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Use of valproates in women of childbearing age and pregnant women with epilepsy | Abstract similar documents |
| P. N. Vlasov | ||
| "... forms, including long-acting or intravenous formulatons, and favorable pharmacokinetic ..." | ||
| Vol 10, No 1 (2018) | Treatment of vertigo in elderly patients with chronic cerebrovascular disease | Abstract similar documents |
| S. N. Duma | ||
| "... who took betahistine 48 mg/day, intravenous Mexidol® 5.0 ml for 10 days, then 375 mg tablets daily ..." | ||
| Vol 10, No 2 (2018) | Effect of mexidol on lipid-phospholipid profile changes in elderly patients with stroke | Abstract similar documents |
| Yu. V. Abramenko | ||
| "... , the modified Rankin scale, and the Barthel index before and during intravenous dropwise infusion of mexidol 500 ..." | ||
| Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
| "... ), subcutaneous glatiramer acetate (copaxone, 20 mg), intravenous natalizumab (tyzabri, 300 mg), and oral ..." | ||
| Vol 5, No 3 (2013) | Diabetic peripheral neuropathy therapy-induced activation of humoral serotonin and endogenous neurotrophins | Abstract similar documents |
| Yuulia Vladimirovna Karakulova, N B Kaigorodova, E A Batueva | ||
| "... to normalize carbohydrate metabolism, 30 patients with DPN received actovegin in an intravenous, jetwise dose ..." | ||
| Vol 16, No 2 (2024) | The use of thromboaspiration and combined treatment in patients with ischemic stroke in real-life clinical practice | Abstract similar documents |
| T. V. Volchenkova, S. V. Kotov, E. V. Isakova, M. V. Sutormin, E. V. Patrin, B. B. Gegenava, M. N. Martynovich, I. G. Rudakova, L. V. Smetana, V. A. Borisova, S. V. Belkina | ||
| "... (intravenous thrombolysis with alteplase followed by aspiration thromboextraction), Group II underwent ..." | ||
| Vol 13, No 4 (2021) | Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders | Abstract PDF (Eng) similar documents |
| S. V. Kotov, E. S. Novikova, A. S. Kotov | ||
| "... and 18 women) aged 20-51 years who received RTX in 2019-2021. The treatment protocol included intravenous ..." | ||
| Vol 12, No 1 (2020) | The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia | Abstract similar documents |
| V. V. Burdakov, D. V. Krasnykh | ||
| "... and atherosclerosis, who received intravenous Mexidol® administered dropwise at a dose of 500 mg once a day for 14 ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... in patients with SPMS. All the patients received a treatment cycle of 600-mg intravenous ocrelizumab ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Experience in using injectable valproic acid (convulex) in patients with serial epileptic seizures and status epilepticus at the prehospital stage | Abstract similar documents |
| A. V. Lebedeva, V. A. Karlov, A. M. Sidorov, V. L. Baratashvili, V. E. Khomutov | ||
| "... четкого фокального начала) – у 24 (75%) больных; в то время как у 8 (25%) пациентов отмечались парциальные ..." | ||
| Vol 1, No 1 (2009) | THE ACUTE PERIOD OF ISCHEMIC STROKE: DIAGNOSIS AND TREATMENT | Abstract similar documents |
| V. A. Parfenov | ||
| "... in a specialized unit, which substantially reduces mortality and disability. The intravenous injection of tissue ..." | ||
| Vol 13, No 1 (2021) | Role of pathogenetic therapy for diabetic polyneuropathy | Abstract similar documents |
| D. A. Iskra, V. V. Kovalchuk, E. R. Barantsevich | ||
| "... the patients used Berlithione: Group 1 received its intravenous doses of 600 mg for 14 days, then oral ones ..." | ||
| Vol 2, No 3 (2010) | Specific features of psychopathological manifestations in criminal clozapine intoxications | Abstract similar documents |
| D. G. Slyundin, A. S. Livanov, V. V. Anuchin, A. G. Merkin, I. G. Bobrinskaya, E. V. Gutova | ||
| "... in the therapy was the use of the antidote intravenous aminostigmine and galantamine bromide in a dose of 2-3 mg ..." | ||
| Vol 4, No 3 (2012) | Specific features of early post-stroke seizures | Abstract similar documents |
| Tatyana Valeryevna Danilova, D R Khasanova, I R Kamalov | ||
| "... возникали при кардиоэмболическом подтипе инсульта в виде простых парциальных приступов. Выявлены ..." | ||
| Vol 16, No 5 (2024) | Gidazepam – daytime tranquilizer for the treatment of anxiety | Abstract similar documents |
| Yu. E. Azimova, D. S. Petelin | ||
| "... свойств: более низкий аффинитет к ГАМКА-рецепторам, чем у классических бензодиазепинов, парциальный ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | The clinical and neurophysiological characteristics of the deja vu phenomenon in epilepsy | Abstract similar documents |
| P. N. Vlasov, A. V. Chervyakov, G. R. Drozhzhina, М. V. Antonyuk, N. V. Orekhova, V. V. Gnezditsky, T. Yu. Noskova, P. A. Fedin | ||
| "... приступа и в структуре парциального и вторично-генерализованного припадка. Основные клинические ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Clinical features of poststroke epileptic seizures | Abstract similar documents |
| T. V. Danilova | ||
| "... обсуждение. Отмечено более частое развитие фокальных приступов, с преобладанием простых парциальных припадков ..." | ||
| Vol 2, No 3 (2010) | Use of depakine chronosphere as a first monotherapy to treat epilepsy in children | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| "... эпилепсии (как парциальных, так и генерализованных). Переносимость Депакин Хроносфера в данном исследовании ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | Efficiency and tolerance of sustained-release valproate sodium (Depakine®ChronosphereТМ) as the drug of the first choice in the treatment of adult epilepsy | Abstract similar documents |
| E. D. Belousova, G. N. Avakyan | ||
| "... эффективным при разных формах эпилепсии (как парциальных, так и генерализованных). Переносимость Депакин ..." | ||
| Vol 2, No 3 (2010) | Clinical experience with ceraxon used in ischemic stroke | Abstract similar documents |
| V. A. Parfenov, T. G. Fateyeva, O. V. Kosivtsova | ||
| "... Цераксона по 2000 мг/сут внутривенно в течение 10 сут, затем внутрь в течение 35 сут с оценкой его влияния ..." | ||
| Vol 4, No 4 (2012) | Citicoline for ischemic stroke: ICTUS trial | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... плацебо в течение 24 ч после появления симптомов (I000 мг каждые I2 ч внутривенно в течение первых 3 дней ..." | ||
| Vol 15, No 2 (2023) | Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis | Abstract similar documents |
| I. A. Gribacheva, T. F. Popova, E. V. Petrova, A. V. Zvonkova | ||
| "... внутривенно капельно (500 мг 1 раз в сутки) в течение 14 дней, с последующим пероральным приемом препарата ..." | ||
| Vol 4, No 3 (2012) | Experience in correcting brain edema in cerebral infarction | Abstract similar documents |
| E V Eliseyev, T Yu Nedorostkova, Sofia Alekseyevna Rumyantseva, V V Afanasyev | ||
| "... первых 3 сут назначали L-лизина эсцинат внутривенно медленно капельно в суточной дозе 10 мл. Результаты ..." | ||
| Vol 6, No 3 (2014) | Effect of citicoline on blood pressure variability | Abstract similar documents |
| O. D. Ostroumova, N. Yu. Taranenko | ||
| "... мг внутривенно капельно, на курс 10 инъекций, далее по 1000 мг/сут внутрь до 3 мес; 30 пациентов ..." | ||
| 1 - 57 of 57 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
